Author
Listed:
- Michal A. Elovitz
(Mirvie Inc.
Nuttall Women’s Health)
- Elaine P. S. Gee
(Mirvie Inc.)
- Nathaniel Delaney-Busch
(Mirvie Inc.)
- Alison B. Moe
(Mirvie Inc.)
- Mitsu Reddy
(Mirvie Inc.)
- Arkady Khodursky
(Mirvie Inc.)
- Johnny La
(Mirvie Inc.)
- Ilma Abbas
(Mirvie Inc.)
- Kay Mekaru
(Mirvie Inc.)
- Hunter Collins
(Mirvie Inc.)
- Farooq Siddiqui
(Mirvie Inc.)
- Rory Nolan
(Mirvie Inc.)
- Rupsa C. Boelig
(Thomas Jefferson University)
- Daniel G. Kiefer
(Women’s Care Florida)
- Pamela M. Simmons
(Woman’s Hospital)
- George R. Saade
(Eastern Virginia Medical School)
- Antonio Saad
(Inova Health)
- Ebony B. Carter
(University of North Carolina at Chapel Hill)
- Thomas F. McElrath
(Mirvie Inc.
Brigham Women’s Hospital)
- Stephen R. Quake
(Stanford University
Chan Zuckerberg Biohub
Stanford University)
- Mark A. DePristo
(BigHat Biosciences Inc.)
- Carrie Haverty
(Mirvie Inc.)
- Manfred Lee
(Mirvie Inc.)
- Eugeni Namsaraev
(Mirvie Inc.)
- Vincenzo Berghella
(Thomas Jefferson University)
- Ai-ris Y. Collier
(Beth Israel Deaconess Medical Center
Harvard Medical School)
- Antonia I. Frolova
(Washington University School of Medicine)
- Esther Park-Hwang
(MultiCare Health System)
- Luis D. Pacheco
(Univerity of Texas Medical Branch)
- Elizabeth F. Sutton
(Woman’s Hospital)
- Maneesh Jain
(Mirvie Inc.)
- Kara Rood
(The Ohio State University)
- William A. Grobman
(The Ohio State University)
- Joseph R. Biggio
(Ochsner Health)
- Cynthia Gyamfi-Bannerman
(University of California San Diego)
- Arun Jeyabalan
(University of Pittsburgh)
- Morten Rasmussen
(Mirvie Inc.)
Abstract
Hypertensive disorders of pregnancy (HDP), including preeclampsia, affect 1 in 6 pregnancies, are major contributors to maternal morbidity and mortality, yet lack precision medicine strategies. Analyzing transcriptomic data from a prospectively-collected diverse cohort (n = 9102), this study reveals distinct RNA subtypes in maternal blood, reclassifying clinical HDP phenotypes like early/late-onset preeclampsia. The placental gene PAPPA2 strongly predicts the most severe forms of preeclampsia in individuals without pre-existing high risk factors, months before symptoms, and its overexpression correlates with earlier delivery in a dose-dependent manner. Further, molecular subtypes characterized by immune genes are upregulated in less severe forms of HDP. These results reclassify HDP clinical phenotypes into two distinct molecular subtypes, placental-associated or immune-associated. Validation performance for placental-associated HDP yields an AUC of 0.88 in the advanced maternal age population without pre-existing high risk factors. Molecular subtypes create new opportunities to apply precision-based medicine in maternal health.
Suggested Citation
Michal A. Elovitz & Elaine P. S. Gee & Nathaniel Delaney-Busch & Alison B. Moe & Mitsu Reddy & Arkady Khodursky & Johnny La & Ilma Abbas & Kay Mekaru & Hunter Collins & Farooq Siddiqui & Rory Nolan & , 2025.
"Molecular subtyping of hypertensive disorders of pregnancy,"
Nature Communications, Nature, vol. 16(1), pages 1-14, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58157-y
DOI: 10.1038/s41467-025-58157-y
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58157-y. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.